Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI)

P. Dewint; B.E. Hansen; E. Verhey; B. Oldenburg; D.W. Hommes; M. Pierik; C.I.J. Ponsioen; H.M. van Dullemen; M. Russel; A.A. van Bodegraven; C.J. van der Woude

doi:10.1136/gutjnl-2013-304488

Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI)

P. Dewint, B.E. Hansen, E. Verhey, B. Oldenburg, D.W. Hommes, M. Pierik, C.I.J. Ponsioen, H.M. van Dullemen, M. Russel, A.A. van Bodegraven, C.J. van der Woude

Gastroenterology and hepatology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	292-299
Journal	Gut
Volume	63
Issue number	2
DOIs	https://doi.org/10.1136/gutjnl-2013-304488
Publication status	Published - 2014

Access to Document

10.1136/gutjnl-2013-304488

Cite this

Dewint, P., Hansen, B. E., Verhey, E., Oldenburg, B., Hommes, D. W., Pierik, M., Ponsioen, C. I. J., van Dullemen, H. M., Russel, M., van Bodegraven, A. A., & van der Woude, C. J. (2014). Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI). Gut, 63(2), 292-299. https://doi.org/10.1136/gutjnl-2013-304488

@article{145b239362174d6b856d9338c0ebb251,

title = "Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI)",

author = "P. Dewint and B.E. Hansen and E. Verhey and B. Oldenburg and D.W. Hommes and M. Pierik and C.I.J. Ponsioen and {van Dullemen}, H.M. and M. Russel and {van Bodegraven}, A.A. and {van der Woude}, C.J.",

year = "2014",

doi = "10.1136/gutjnl-2013-304488",

language = "Undefined/Unknown",

volume = "63",

pages = "292--299",

journal = "Gut",

issn = "0017-5749",

publisher = "BMJ Publishing Group",

number = "2",

}

Dewint, P, Hansen, BE, Verhey, E, Oldenburg, B, Hommes, DW, Pierik, M, Ponsioen, CIJ, van Dullemen, HM, Russel, M, van Bodegraven, AA & van der Woude, CJ 2014, 'Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI)', Gut, vol. 63, no. 2, pp. 292-299. https://doi.org/10.1136/gutjnl-2013-304488

TY - JOUR

T1 - Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI)

AU - Dewint, P.

AU - Hansen, B.E.

AU - Verhey, E.

AU - Oldenburg, B.

AU - Hommes, D.W.

AU - Pierik, M.

AU - Ponsioen, C.I.J.

AU - van Dullemen, H.M.

AU - Russel, M.

AU - van Bodegraven, A.A.

AU - van der Woude, C.J.

PY - 2014

Y1 - 2014

U2 - 10.1136/gutjnl-2013-304488

DO - 10.1136/gutjnl-2013-304488

M3 - Article

C2 - 23525574

SN - 0017-5749

VL - 63

SP - 292

EP - 299

JO - Gut

JF - Gut

IS - 2

ER -